Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth K Leung

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Elife|September 4, 2014
T cell-specific inhibition of multiple apoptotic pathways blocks negative selection and causes autoimmunityMegan L Burger, Kenneth K Leung, Margaux J Bennett, et al.
Journal of Diabetes Science and Technology|April 2, 2026
Smartphone-based App to Assess Diabetic Peripheral NeuropathyRachel A G Adenekan, Adeyinka E Adenekan, Kenneth K Leung, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Smartphone-based App to Assess Diabetic Peripheral NeuropathyRachel A G Adenekan, Adeyinka E Adenekan, Kenneth K Leung, et al.
Muscle & Nerve|September 11, 2023
Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practiceNakul Katyal, Karen Halldorsdottir, Raghav Govindarajan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Elife|September 4, 2014
T cell-specific inhibition of multiple apoptotic pathways blocks negative selection and causes autoimmunityMegan L Burger, Kenneth K Leung, Margaux J Bennett, et al.
Journal of Diabetes Science and Technology|April 2, 2026
Smartphone-based App to Assess Diabetic Peripheral NeuropathyRachel A G Adenekan, Adeyinka E Adenekan, Kenneth K Leung, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Smartphone-based App to Assess Diabetic Peripheral NeuropathyRachel A G Adenekan, Adeyinka E Adenekan, Kenneth K Leung, et al.
Muscle & Nerve|September 11, 2023
Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practiceNakul Katyal, Karen Halldorsdottir, Raghav Govindarajan, et al.
Pageof 1